Cargando…

VIPhyb, an Antagonist of Vasoactive Intestinal Peptide Receptor, Enhances Cellular Antiviral Immunity in Murine Cytomegalovirus Infected Mice

Vasoactive intestinal peptide (VIP) is a neuropeptide hormone that suppresses Th1-mediated cellular immunity. We previously reported that VIP-knockout (VIP-KO) mice have enhanced cellular immune responses and increased survival following murine cytomegalovirus (mCMV) infection in C57BL/6 mice. In th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jian-Ming, Darlak, Kasia A., Southerland, Lauren, Hossain, Mohammad S., Jaye, David L., Josephson, Cassandra D., Rosenthal, Hilary, Waller, Edmund K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664580/ https://www.ncbi.nlm.nih.gov/pubmed/23723978 http://dx.doi.org/10.1371/journal.pone.0063381

Ejemplares similares

Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML
por: Petersen, Christopher, et al.
Publicado: (2015)

Gene Expression Analysis Links Autocrine Vasoactive Intestinal Peptide and ZEB1 in Gastrointestinal Cancers
por: Rao, Ishani H., et al.
Publicado: (2023)

The Human Cytomegalovirus Major Immediate-Early Proteins as Antagonists of Intrinsic and Innate Antiviral Host Responses
por: Paulus, Christina, et al.
Publicado: (2009)

Amphipathic DNA polymers exhibit antiviral activity against systemic Murine Cytomegalovirus infection
por: Cardin, Rhonda D, et al.
Publicado: (2009)

Selective Inhibition of Murine Cytomegalovirus Viral Gene Expression by the Antiviral Peptide TAT-I24
por: Harant, Hanna
Publicado: (2022)

Decoding murine cytomegalovirus
por: Lodha, Manivel, et al.
Publicado: (2023)

Dynamics of the Cellular Metabolome during Human Cytomegalovirus Infection
por: Munger, Joshua, et al.
Publicado: (2006)

Heart Dysfunction Following Long-Term Murine Cytomegalovirus Infection: Fibrosis, Hypertrophy, and Tachycardia
por: Bonavita, Cassandra M., et al.
Publicado: (2020)

Vasoactive Hormones and the Diabetic Kidney
por: Maric, Christine
Publicado: (2008)

Weaning order of vasoactive drugs
por: Michels, Vilto, et al.
Publicado: (2019)

Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
por: Ozkan, Tanju Basarir, et al.
Publicado: (2007)

Host bone marrow-derived IL-12 enhances donor T cell engraftment in a mouse model of bone marrow transplantation
por: Darlak, Katarzyna A, et al.
Publicado: (2014)

MURINE CYTOMEGALOVIRUS INFECTION OF PHAGOCYTIC LEUKOCYTES
por: Bale, James F, et al.
Publicado: (1984)

Vasodilatory Effect of the Stable Vasoactive Intestinal Peptide Analog RO 25-1553 in Murine and Rat Lungs
por: Yin, Jun, et al.
Publicado: (2013)

UNC93B1 Mediates Innate Inflammation and Antiviral Defense in the Liver during Acute Murine Cytomegalovirus Infection
por: Crane, Meredith J., et al.
Publicado: (2012)

Observational study of cytomegalovirus from breast milk and necrotising enterocolitis
por: Patel, Ravi Mangal, et al.
Publicado: (2020)

Prevention of Cellular Suicide by Cytomegaloviruses
por: Fliss, Patricia M., et al.
Publicado: (2012)

Comparison of vasoactive-inotropic score, vasoactive-ventilation-renal score, and modified vasoactive-ventilation-renal score for predicting the poor prognosis after coronary artery bypass grafting
por: Du, Yanping, et al.
Publicado: (2023)

Vasoactive-Inotropic Score and Vasoactive-Ventilation-Renal Score as Outcome Predictors for Children on Extracorporeal Membrane Oxygenation
por: Shukla, Ira, et al.
Publicado: (2021)

Antiviral prophylaxis inhibits cytomegalovirus reactivation in critical illness
por: Cowley, NJ, et al.
Publicado: (2015)

Antiviral Agents as Therapeutic Strategies Against Cytomegalovirus Infections
por: Chen, Shiu-Jau, et al.
Publicado: (2019)

Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
por: Pinninti, Swetha, et al.
Publicado: (2023)

Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016)

Response to “Weaning order of vasoactive drugs”
por: Jeon, Kyeongman, et al.
Publicado: (2019)

The Vasoactive Mas Receptor in Essential Hypertension
por: Povlsen, Amalie L., et al.
Publicado: (2020)

Control of Murine Cytomegalovirus Infection by γδ T Cells
por: Sell, Sabrina, et al.
Publicado: (2015)

Murine Cytomegalovirus Spreads by Dendritic Cell Recirculation
por: Farrell, Helen E., et al.
Publicado: (2017)

The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection
por: Landázuri, Natalia, et al.
Publicado: (2021)

Cortisol regulates the paracrine action of macrophages by inducing vasoactive gene expression in endometrial cells
por: Thiruchelvam, Uma, et al.
Publicado: (2016)

Development of a mouse salivary gland-derived mesenchymal cell line for immunological studies of murine cytomegalovirus
por: White, Timothy M., et al.
Publicado: (2022)

Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression
por: Zhu, Jingru, et al.
Publicado: (2022)

Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients
por: Göhring, Katharina, et al.
Publicado: (2015)

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
por: Krishna, B. A., et al.
Publicado: (2017)

Antiviral-resistant cytomegalovirus infections in solid organ transplantation in the Netherlands
por: Van Leer Buter, Coretta C, et al.
Publicado: (2019)

An Update on Current Antiviral Strategies to Combat Human Cytomegalovirus Infection
por: Panda, Kingshuk, et al.
Publicado: (2023)

Antiviral Approach to Cytomegalovirus Infection: An Overview of Conventional and Novel Strategies
por: Bottino, Paolo, et al.
Publicado: (2023)

A Review of Murine Cytomegalovirus as a Model for Human Cytomegalovirus Disease—Do Mice Lie?
por: Fisher, Michelle A., et al.
Publicado: (2020)

Splanchnic Haemodynamics and Vasoactive Agents in Experimental Cirrhosis
por: Geraghty, J. G., et al.
Publicado: (1994)

The Vasoactive Potential of Kisspeptin-10 in the Peripheral Vasculature
por: Sawyer, Iain, et al.
Publicado: (2011)

Epinephrine: Is it really the black sheep of vasoactive agents?
por: Agrawal, Ritwick, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_v2ef4c1man29h640ma308f2fsa